Home / Cell Viability/Proliferation Assays / MycoProbe Mycoplasma Detection Kit

MycoProbe Mycoplasma Detection Kit

Catalog #: CUL001B
112 Citations 6 Reviews Datasheet / COA / SDS
Mycoplasmas Detected: M. hyorhinis, M. arginini, M. fermentans, M. orale, M. pirum, M. hominis, M. salivarium, Acholeplasma laidlawii
Catalog # Availability Size / Price Qty
CUL001B
Mycoplasma Detection in Cell Line Supernates and Cell Lysates. 
1 Image
Product Details
Procedure
Citations (112)
FAQs
Reviews (6)
Summary Product Datasheets Data Images

MycoProbe Mycoplasma Detection Kit Summary

A complete kit to detect common antibiotic-resistant cell culture contaminants

Key Benefits

  • Reduces experimental variation
  • Accurate and highly sensitive
  • Simple multiwell-based colorimetric assay
  • Only takes 4.5 hours

 

Why should I be worried about mycoplasma contamination?

Mycoplasma contamination affects up to 80% of continuous cell cultures. If undetected, mycoplasma contamination can have significant effects on the quality and reliability of your cell culture preparations.

Mycoplasma contamination:

  • Induces deleterious effects on cell culture quality.
  • Alters the phenotypic characteristics of host cells.
  • Increases experimental variation.
  • Is common in eukaryotic cell cultures.
  • Is resistant to antibiotics such as penicillin and streptomycin.
  • Has multiple sources (i.e. personnel, reagents, other infected cells).

Mycoplasma are difficult to detect because they:

  • Are not visible using standard microscopes.
  • Are small enough to pass through 0.45 mm sterilization filters.
  • Do not produce changes in culture medium color, pH, or turbidit

What is the best method to determine if my cultured cells are mycoplasma-contaminated?

To provide an accurate and highly sensitive tool for routine screening of mycoplasma contamination in cultured cells, R&D Systems developed the MycoProbe Mycoplasma Detection Assay. This assay detects Mycoplasma 16S ribosomal RNA (rRNA) using a colorimetric signal amplification system with sensitivity comparable to PCR. The MycoProbe assay is not susceptible to common problems encountered with PCR-based mycoplasma detection kits.

The MycoProbe Mycoplasma Detection Assay:

  • Detects the eight mycoplasma species known to cause 95% of eukaryotic cell culture contamination.
  • Is highly sensitive (comparable to PCR).
  • Is compatible with high-throughput screening.
  • Does not generate false positives from amplicon contamination.
  • Can be used for cell culture supernatants or cultured cell pellets.
  • Can be used with samples from fresh or frozen cells.
  • Does not require cells to be cultured in antibiotic-free media.
  • Includes a synthetic DNA oligonucleotide positive control.
  • Generates results in 4.5 hours.

Alternative Methods for Mycoplasma Detection

Technique

Advantage

Disadvantage
Microbiological culture Most sensitive
  • Takes 2 to 4 weeks
  • Cannot detect fastidious mycoplasma
  • Requires specialized laboratory conditions
Fluorescent DNA staining Efficient
  • Cannot detect mycoplasma that cyto-absorb poorly
ELISA of cell surface antigens Common technique
  • Low sensitivity
PCR-based detection High sensitivity
  • Prone to both false positives and false negatives
Biochemical activity Common technique
  • Inconsistent results across cell lines
Kit Components

The MycoProbeTM Mycoplasma Detection Kit (Catalog # CUL001B) contains enough reagents to assay one 96-well plate for mycoplasma contamination.

  • Cell Lysis Diluent Concentrate - 2 vials (1.7 mL/vial) of a 10-fold concentrated solution
  • Hybridization Plate - One 96 well polystyrene microplate
  • Streptavidin Plate - One 96 well polystyrene microplate (12 strips of 8 wells) coated with streptavidin
  • Sample Diluent - 2 vials (21 mL/vial) of a buffered protein solution with preservatives
  • Anti-digoxigenin Conjugate - 21 mL of a polyclonal antibody against digoxigenin conjugated to alkaline phosphatase with preservatives
  • Capture Probes - 1.1 mL of a six-fold concentrated stock solution
  • Detection Probes - 1.1 mL of a six-fold concentrated stock solution
  • Positive Control - 1.1 mL of a solution containing a synthetic DNA oligonucleotide
  • Wash Buffer Concentrate - 100 mL of a 10-fold concentrated solution with preservatives
  • Substrate - 1 vial of lyophilized NADPH with stabilizers
  • Substrate Diluent - 1 vial (7 mL) of a buffered solution with stabilizers
  • Amplifier - 1 vial of lyophilized amplifier enzymes with stabilizers
  • Amplifier Diluent - 1 vial (7 mL) of a buffered solution containing INT-violet with stabilizers
  • Stop Solution - 6 mL of 2 N sulfuric acid
  • Float Collar - Microplate float collar for water bath
  • Plate Sealers - 12 adhesive strips
Precautions

The Wash Buffer supplied in this kit contains sodium azide, which may react with lead and copper plumbing to form explosive metallic azides. Flush with large volumes of water during disposal.

The Stop Solution provided with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.

When handling cell culture samples, appropriate precautions should be taken to prevent exposure to mycoplasma and other hazardous biological agents.

Specifications

Shipping Conditions
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Scientific Data

Mycoplasma Detection Mycoplasma Detection in Cell Line Supernates and Cell Lysates.  View Larger

Mycoplasma Detection in Cell Line Supernates and Cell Lysates.  The presence of the eight mycoplasma species known to cause 95% of eukaryotic cell culture contamination was tested in supernates and cell lysates of the indicated cell lines using the MycoProbe Mycoplasma Detection Kit (Catalog # CUL001B). The average of the duplicate optical density (OD) readings for each control and sample was determined. The average negative control OD value was subtracted from all average sample OD values. A calculated positive control OD value of >0.10 indicated mycoplasma contamination (black line) in the CTLL-2, BaF3, A431, and K562 (cell lysate 1) samples. Abbreviations: CTLL-2 mouse cytotoxic T cell line, BaF3 mouse pro-B cell line, HepG2 human hepatocellular carcinoma cell line, A431 human epithelial carcinoma cell line, and K562 human chronic myelogenous leukemia cell line.

Assay Procedure

Refer to the product datasheet for complete product details.

Briefly, mycoplasma contamination can be evaluated in cell culture supernates or cell pellets using this straightforward procedure:

  • Samples are lysed and hybridized with biotin-labeled capture oligonucleotide probes
  • Digoxigenin-labeled detection probes target the eight most common mycoplasma contaminants
  • Following signal amplification, multiwells are measured using a standard colorimetric plate reader
  • Results are generated in 4.5 hours
CUL001B Protocol Graphic Summary
View Graphic Procedure
 

 

Reagents Provided

Reagents supplied in the MycoProbe Mycoplasma Detection Kit (Catalog # CUL001B):

  • Cell Lysis Diluent Concentrate - 2 vials (1.7 mL/vial) of a 10-fold concentrated solution
  • Hybridization Plate - One 96 well polystyrene microplate
  • Streptavidin Plate - One 96 well polystyrene microplate (12 strips of 8 wells) coated with streptavidin
  • Sample Diluent - 2 vials (21 mL/vial) of a buffered protein solution with preservatives
  • Anti-digoxigenin Conjugate - 21 mL of a polyclonal antibody against digoxigenin conjugated to alkaline phosphatase with preservatives
  • Capture Probes - 1.1 mL of a six-fold concentrated stock solution
  • Detection Probes - 1.1 mL of a six-fold concentrated stock solution
  • Positive Control - 1.1 mL of a solution containing a synthetic DNA oligonucleotide
  • Wash Buffer Concentrate - 100 mL of a 10-fold concentrated solution with preservatives
  • Substrate - 1 vial of lyophilized NADPH with stabilizers
  • Substrate Diluent - 1 vial (7 mL) of a buffered solution with stabilizers
  • Amplifier - 1 vial of lyophilized amplifier enzymes with stabilizers
  • Amplifier Diluent - 1 vial (7 mL) of a buffered solution containing INT-violet with stabilizers
  • Stop Solution - 6 mL of 2 N sulfuric acid
  • Float Collar - Microplate float collar for water bath
  • Plate Sealers - 12 adhesive strips

 

Other Supplies Required

Reagents

  • Deionized water, RNase-free
  • Cell samples of interest

Materials

  • Pipettes and pipette tips
  • Squirt bottle or manifold dispenser
  • 100 mL and 1,000 mL graduated cylinders for preparation of Wash Buffer
  • Gloves and mask

Equipment

  • Microplate reader capable of measuring absorbance at 490 nm with the correction wavelength set at 650 nm or 690 nm
  • Horizontal orbital microplate shaker (0.12" orbit) capable of maintaining a speed of 500 + 50 rpm
  • 65 + 1 °C water bath
  • Vortex mixer

 

Procedure Overview

R&D Systems Protocol for Mouse Treg Cell Differentiation

Wash the Hybridization Plate 2 times with Wash Buffer.

Add diluted Probes, Positive Control, Sample Diluent (Negative Control), or sample to the designated wells.

Incubate the plate for 60 minutes in a 65 °C water bath.

Protocol for Mouse Treg Cell Differentiation Step 1

Wash the Streptavidin Plate 2 times with Wash Buffer.

Transfer 150 µL from each well of the Hybridization Plate to the Streptavidin Plate.

Incubate for 60 minutes on a horizontal orbital shaker.

Protocol for Mouse Treg Cell Differentiation Step 2

Wash the Streptavidin Plate 4 times with Wash Buffer.

Add Anti-Digoxigenin Conjugate to each well.

Incubate for 60 minutes on a shaker.

Protocol for Mouse Treg Cell Differentiation Step 3

Wash the Streptavidin Plate 6 times with Wash Buffer.

Add Substrate Solution to each well.

Incubate for 60 minutes on a shaker.
Do not wash.

Protocol for Mouse Treg Cell Differentiation Step 4

Add Amplifier Solution to each well.

Incubate for 30 minutes on a shaker.
Do not wash.

Protocol for Mouse Treg Cell Differentiation Step 5

Add Stop Solution to each well.

Determine the optical density (OD) of each well within 30 minutes, using a microplate reader set to 490 nm.

Protocol for Mouse Treg Cell Differentiation Step 6

Note: If wavelength correction is available, set to 650 nm or 690 nm. If wavelength correction is not available, subtract readings at 650 nm or 690 nm from the readings at 490 nm. This subtraction will correct for optical imperfections in the plate. Readings made directly at 490 nm without correction may be higher and less accurate.

 
 
Calculation of Results

Determine the average of the duplicate optical density (OD) readings for each control and sample. Subtract the average negative control OD value from all average OD values. The calculated positive control OD value should be > 1.5.

OD Values (Calculated)

Result

Interpretation
< 0.05 Negative No mycoplasma detected
0.05 – 0.10 Inconclusive Sample is suspect for mycoplasma. Continue to culture for an additional 2 - 3 days and repeat the test. If sample gives a similar OD, then no mycoplasma are detected.
> 0.10 Positive Mycoplasma detected

Citations for MycoProbe Mycoplasma Detection Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

112 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic beta-cell failure
    Authors: A Cercillieu, J Ratajczak, M Joffraud, JL Sanchez-Ga, G Jacot, A Zollinger, S Métairon, J Giroud-Ger, M Rumpler, E Ciarlo, M Valera-Alb, A Sambeat, C Canto
    Molecular Metabolism, 2022;0(0):101605.  2022
  2. Molecular basis of crosstalk in nuclear receptors: heterodimerization between PXR and CAR and the implication in gene regulation
    Authors: MN Bwayi, E Garcia-Mal, SC Chai, B Xie, S Chodankar, AD Huber, J Wu, K Annu, WC Wright, HM Lee, J Seetharama, J Wang, CD Buchman, J Peng, T Chen
    Nucleic Acids Research, 2022;0(0):.  2022
  3. Long-term anti-tumor effects following both conventional radiotherapy and FLASH in fully immunocompetent animals with glioblastoma
    Authors: E Liljedahl, E Konradsson, E Gustafsson, KF Jonsson, JK Olofsson, C Ceberg, HN Redebrandt
    Scientific Reports, 2022;12(1):12285.  2022
  4. Cell-autonomous Hedgehog signaling controls Th17 polarization and pathogenicity
    Authors: J Hanna, F Beke, LM O'Brien, C Kapeni, HC Chen, V Carbonaro, AB Kim, K Kishore, TE Adolph, MO Skjoedt, K Skjoedt, M de la Roch, M de la Roch
    Nature Communications, 2022;13(1):4075.  2022
  5. In vitro radiosensitization of breast cancer with hypoxia-activated prodrugs
    Authors: R Aiyappa-Ma, L Elsalem, AIM Ibrahim, K Pors, SG Martin
    Journal of Cellular and Molecular Medicine, 2022;0(0):.  2022
  6. Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model
    Authors: E Konradsson, E Liljedahl, E Gustafsson, G Adrian, S Beyer, SE Ilaahi, K Petersson, C Ceberg, H Nittby Red
    Advances in radiation oncology, 2022;7(6):101011.  2022
  7. Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression
    Authors: DM Beauvais, SE Nelson, KM Adams, NA Stueven, O Jung, AC Rapraeger
    The Journal of Biological Chemistry, 2022;0(0):102029.  2022
  8. [89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer
    Authors: S Lee, A Cavaliere, JD Gallezot, T Keler, SK Michelhaug, E Belitzky, M Liu, T Mulnix, SE Maher, ALM Bothwell, F Li, M Phadke, S Mittal, B Marquez-No
    Molecular Cancer Therapeutics, 2022;21(3):440-447.  2022
  9. Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
    Authors: Y Xiao, J Chen, H Zhou, X Zeng, Z Ruan, Z Pu, X Jiang, A Matsui, L Zhu, Z Amoozgar, DS Chen, X Han, DG Duda, J Shi
    Nature Communications, 2022;13(1):758.  2022
  10. Galvanic current activates the NLRP3 inflammasome to promote Type I collagen production in tendon
    Authors: A Peñin-Fran, JA García-Vid, CM Martínez, P Escolar-Re, RM Martínez-O, AI Gómez, JM Bueno, F Minaya-Muñ, F Valera-Gar, F Medina-Mir, P Pelegrín
    Elife, 2022;11(0):.  2022
  11. Evolutionary analyses of the gasdermin family suggest conserved roles in infection response despite loss of pore-forming functionality
    Authors: D Angosto-Ba, C Alarcón-Vi, L Hurtado-Na, MC Baños, J Rivers-Aut, P Pelegrín
    Bmc Biology, 2022;20(1):9.  2022
  12. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer
    Authors: JJ McGuire, JS Frieling, CH Lo, T Li, A Muhammad, HR Lawrence, NJ Lawrence, LM Cook, CC Lynch
    Nature Communications, 2021;12(1):723.  2021
  13. Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
    Authors: N Mao, Z Zhang, YS Lee, D Choi, AA Rivera, D Li, C Lee, S Haywood, X Chen, Q Chang, G Xu, HA Chen, E de Stanchi, C Sawyers, N Rosen, AC Hsieh, Y Chen, BS Carver
    Nature Communications, 2021;12(1):5053.  2021
  14. Liquid biopsy genotyping by a simple lateral flow strip assay with visual detection
    Authors: P Kalligosfy, S Nikou, V Bravou, DP Kalogianni
    Analytica chimica acta, 2021;1163(0):338470.  2021
  15. Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer
    Authors: B Cen, J Wei, D Wang, Y Xiong, JW Shay, RN DuBois
    Oncogene, 2021;0(0):.  2021
  16. A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer
    Authors: S Khalafi, S Zhu, R Khurana, I Lohse, S Giordano, S Corso, H Al-Ali, SP Brothers, C Wahlestedt, S Schürer, W El-Rifai
    Translational Oncology, 2021;15(1):101260.  2021
  17. Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2
    Authors: DH Kim, H Park, YJ Choi, MH Kang, TK Kim, CG Pack, CM Choi, JC Lee, JK Rho
    Cell Death & Disease, 2021;12(8):747.  2021
  18. Long-Chain Acylcarnitines Decrease the Phosphorylation of the Insulin Receptor at Tyr1151 Through a PTP1B-Dependent Mechanism
    Authors: K Vilks, M Videja, M Makrecka-K, M Katkevics, E Sevostjano, A Grandane, M Dambrova, E Liepinsh
    International Journal of Molecular Sciences, 2021;22(12):.  2021
  19. MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling
    Authors: L Yin, J Li, J Wang, T Pu, J Wei, Q Li, BJ Wu
    Oncogene, 2021;0(0):.  2021
  20. Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer
    Authors: Z Wang, Y Goto, MM Allevato, VH Wu, R Saddawi-Ko, M Gilardi, D Alvarado, BS Yung, A O'Farrell, AA Molinolo, U Duvvuri, JR Grandis, JA Califano, EEW Cohen, JS Gutkind
    Nature Communications, 2021;12(1):2383.  2021
  21. The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects
    Authors: H Takagi, K Kaji, N Nishimura, K Ishida, H Ogawa, H Takaya, H Kawaratani, K Moriya, T Namisaki, T Akahane, A Mitoro, H Yoshiji
    Cells, 2021;10(3):.  2021
  22. Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver
    Authors: L Liu, B Dai, R Li, Z Liu, Z Zhang
    Theranostics, 2021;11(1):194-208.  2021
  23. Autophagy-competent mitochondrial translation elongation factor TUFM inhibits caspase-8-mediated apoptosis
    Authors: CY Choi, MT Vo, J Nicholas, YB Choi
    Cell Death and Differentiation, 2021;0(0):.  2021
  24. NAD+ boosting reduces age-associated amyloidosis and restores mitochondrial homeostasis in muscle
    Authors: M Romani, V Sorrentino, CM Oh, H Li, TI de Lima, H Zhang, M Shong, J Auwerx
    Cell Reports, 2021;34(3):108660.  2021
  25. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2
    Authors: Y Gu, J Cao, X Zhang, H Gao, Y Wang, J Wang, J He, X Jiang, J Zhang, G Shen, J Yang, X Zheng, G Hu, Y Zhu, S Du, Y Zhu, R Zhang, J Xu, F Lan, D Qu, G Xu, Y Zhao, D Gao, Y Xie, M Luo, Z Lu
    Cell Research, 2021;0(0):.  2021
  26. Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity
    Authors: J Guo, Y Liang, D Xue, J Shen, Y Cai, J Zhu, YX Fu, H Peng
    Cell Research, 2021;0(0):.  2021
  27. A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
    Authors: SM Perez, J Dimastroma, CN Landen, KA Kelly
    Cells, 2021;10(9):.  2021
  28. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model
    Authors: H Tsukui, H Horie, K Koinuma, H Ohzawa, Y Sakuma, Y Hosoya, H Yamaguchi, K Yoshimura, AK Lefor, N Sata, J Kitayama
    BMC Cancer, 2020;20(1):411.  2020
  29. Toxoplasma gondii dense granule protein GRA24 drives MyD88-independent p38 MAPK activation, IL-12 production and induction of protective immunity
    Authors: HL Mercer, LM Snyder, CM Doherty, BA Fox, DJ Bzik, EY Denkers
    PLoS Pathog., 2020;16(5):e1008572.  2020
  30. MAFB promotes cancer stemness and tumorigenesis in osteosarcoma through a Sox9-mediated positive feedback loop
    Authors: Y Chen, B Wang, M Huang, T Wang, C Hu, Q Liu, D Han, C Chen, J Zhang, Z Li, C Liu, W Lei, Y Chang, M Wu, D Xiang, Y Chen, R Wang, W Huang, Z Lei, X Chu
    Cancer Res., 2020;0(0):.  2020
  31. EIF3H orchestrates Hippo pathway-mediated oncogenesis via catalytic control of YAP stability
    Authors: Z Zhou, H Zhou, L Ponzoni, A Luo, R Zhu, M He, Y Huang, KL Guan, I Bahar, Z Liu, Y Wan
    Cancer Res., 2020;0(0):.  2020
  32. Comprehensive RNA-Seq profiling of the lung transcriptome of Bashbay sheep in response to experimental Mycoplasma ovipneumoniae infection
    Authors: Z Du, Y Sun, J Wang, H Liu, Y Yang, N Zhao
    PLoS ONE, 2020;15(7):e0214497.  2020
  33. KANSL2 and MBNL3 are regulators of pancreatic ductal adenocarcinoma invasion
    Authors: PO Oladimeji, J Bakke, WC Wright, T Chen
    Sci Rep, 2020;10(1):1485.  2020
  34. &alpha-Linolenic acid but not linolenic acid protects against hypertension: critical role of SIRT3 and autophagic flux
    Authors: G Li, X Wang, H Yang, P Zhang, F Wu, Y Li, Y Zhou, X Zhang, H Ma, W Zhang, J Li
    Cell Death Dis, 2020;11(2):83.  2020
  35. Oncogenic ERG represses PI3K signaling through down-regulation of IRS2
    Authors: N Mao, D Gao, W Hu, S Gadal, H Hieronymus, S Wang, YS Lee, P Sullivan, Z Zhang, D Choi, N Rosen, CL Sawyers, A Gopalan, Y Chen, BS Carver
    Cancer Res., 2020;0(0):.  2020
  36. Inhibition of miR-17~92 Cluster Ameliorates High Glucose-Induced Podocyte Damage
    Authors: X Fan, Z Hao, Z Li, X Wang, J Wang
    Mediators Inflamm., 2020;2020(0):6126490.  2020
  37. Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy
    Authors: E Roger, J Gout, F Arnold, AK Beutel, M Müller, A Abaei, TFE Barth, V Rasche, T Seufferlei, L Perkhofer, A Kleger
    Cells, 2020;9(9):.  2020
  38. Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
    Authors: A Abdullah, SS Akhand, JSP Paez, W Brown, L Pan, S Libring, M Badamy, E Dykuizen, L Solorio, W Andy Tao, MK Wendt
    Oncogene, 2020;0(0):.  2020
  39. Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake
    Authors: C Dunnill, K Ibraheem, M Peake, M Ioannou, M Palmer, A Smith, A Collett, NT Georgopoul
    PLoS ONE, 2020;15(10):e0240454.  2020
  40. Novel oral plasminogen activator inhibitor?1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats
    Authors: R Noguchi, K Kaji, T Namisaki, K Moriya, H Kawaratani, M Kitade, H Takaya, Y Aihara, A Douhara, K Asada, N Nishimura, T Miyata, H Yoshiji
    Molecular Medicine Reports, 2020;0(0):.  2020
  41. BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer
    Authors: GYL Lui, R Shaw, FX Schaub, IN Stork, KE Gurley, C Bridgwater, RL Diaz, R Rosati, HA Swan, TA Ince, TC Harding, VK Gadi, BA Goff, CJ Kemp, EM Swisher, C Grandori
    EBioMedicine, 2020;60(0):102988.  2020
  42. Redox homeostasis maintained by GPX4 facilitates STING activation
    Authors: M Jia, D Qin, C Zhao, L Chai, Z Yu, W Wang, L Tong, L Lv, Y Wang, J Rehwinkel, J Yu, W Zhao
    Nat. Immunol., 2020;21(7):727-735.  2020
  43. Inhibition of miR-17~92 Cluster Ameliorates High Glucose-Induced Podocyte Damage
    Authors: X Fan, Z Hao, Z Li, X Wang, J Wang
    Mediators Inflamm., 2020;2020(0):6126490.  2020
  44. Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T cell immune memory
    Authors: S Qi, L Lu, F Zhou, Y Chen, M Xu, L Chen, X Yu, WR Chen, Z Zhang
    Theranostics, 2020;10(4):1814-1832.  2020
  45. Mechanical stimulation of human dermal fibroblasts regulates pro-inflammatory cytokines: potential insight into soft tissue manual therapies
    Authors: A Anloague, A Mahoney, O Ogunbekun, TA Hiland, WR Thompson, B Larsen, MT Loghmani, JM Hum, JW Lowery
    BMC Res Notes, 2020;13(1):400.  2020
  46. Evaluation of chemotherapy and P2Et extract combination in ex-vivo derived tumor mammospheres from breast cancer patients
    Authors: C Urueña, TA Sandoval, P Lasso, M Tawil, A Barreto, L Torregrosa, S Fiorentino
    Sci Rep, 2020;10(1):19639.  2020
  47. Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
    Authors: M Terai, E Londin, A Rochani, E Link, B Lam, G Kaushal, A Bhushan, M Orloff, T Sato
    Cancers (Basel), 2020;12(2):.  2020
  48. Loss of the transcription factor MAFB limits beta-cell derivation from human PSCs
    Authors: R Russell, PP Carnese, TG Hennings, EM Walker, HA Russ, JS Liu, S Giacometti, R Stein, M Hebrok
    Nat Commun, 2020;11(1):2742.  2020
  49. The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma
    Authors: C Joseph, MA Alsaleem, MS Toss, YA Kariri, M Althobiti, S Alsaeed, AI Aljohani, PL Narasimha, NP Mongan, AR Green, EA Rakha
    Cancers, 2020;13(1):.  2020
  50. Dysregulated Tgfbr2/ERK-Smad4/SOX2 signaling promotes lung squamous cell carcinoma formation
    Authors: Y Wang, X Tan, Y Tang, C Zhang, J Xu, J Zhou, X Cheng, N Hou, W Liu, G Yang, Y Teng, X Yang
    Cancer Res., 2019;0(0):.  2019
  51. Investigation of Genetic Susceptibility to Blastomycosis Reveals Interleukin-6 as a Potential Susceptibility Locus
    Authors: RM Merkhofer, MB O'Neill, D Xiong, N Hernandez-, H Dobson, JS Fites, AC Shockey, M Wuethrich, CS Pepperell, BS Klein
    MBio, 2019;10(3):.  2019
  52. Genome-wide miRNA profiling and pivotal roles of miRs 125a-5p and 17-92 cluster in human neutrophil maturation and differentiation of acute myeloid leukemia cells
    Authors: EH Dakir, F Mollinedo
    Oncotarget, 2019;10(51):5313-5331.  2019
  53. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
    Authors: L Miao, L Li, Y Huang, D Delcassian, J Chahal, J Han, Y Shi, K Sadtler, W Gao, J Lin, JC Doloff, R Langer, DG Anderson
    Nat. Biotechnol., 2019;0(0):.  2019
  54. Centrosome amplification in cancer disrupts autophagy and sensitizes to autophagy inhibition
    Authors: RA Denu, G Kaur, MM Sass, A Lakkaraju, ME Burkard
    Mol. Cancer Res., 2019;0(0):.  2019
  55. Chloramphenicol Mitigates Oxidative Stress by Inhibiting Translation of Mitochondrial Complex I in Dopaminergic Neurons of Toxin-Induced Parkinson's Disease Model
    Authors: J Han, SJ Kim, MJ Ryu, Y Jang, MJ Lee, X Ju, YL Lee, J Cui, M Shong, JY Heo, GR Kweon
    Oxid Med Cell Longev, 2019;2019(0):4174803.  2019
  56. Influence of Vitamin D on Corneal Epithelial Cell Desmosomes and Hemidesmosomes
    Authors: X Lu, MA Watsky
    Invest. Ophthalmol. Vis. Sci., 2019;60(13):4074-4083.  2019
  57. Activation of NIX-mediated mitophagy by an interferon regulatory factor homologue of human herpesvirus
    Authors: MT Vo, BJ Smith, J Nicholas, YB Choi
    Nat Commun, 2019;10(1):3203.  2019
  58. Aberrant expression of ERG promotes resistance to combined PI3K and AR pathway inhibition through maintenance of AR target genes
    Authors: N Mao, D Gao, W Hu, H Hieronymus, S Wang, YS Lee, C Lee, D Choi, A Gopalan, Y Chen, BS Carver
    Mol. Cancer Ther., 2019;0(0):.  2019
  59. Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells
    Authors: J Bakke, WC Wright, AE Zamora, P Oladimeji, JC Crawford, CT Brewer, RJ Autry, WE Evans, PG Thomas, T Chen
    BMC Cancer, 2019;19(1):253.  2019
  60. CD38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma
    Authors: CR Marlein, RE Piddock, JJ Mistry, L Zaitseva, C Hellmich, RH Horton, Z Zhou, MJ Auger, KM Bowles, SA Rushworth
    Cancer Res., 2019;0(0):.  2019
  61. O-GlcNAcylation of the tumor suppressor FOXO3 triggers aberrant cancer cell growth
    Authors: H Shin, HJ Cha, K Na, MJ Lee, JY Cho, CY Kim, EK Kim, CM Kang, H Kim, YK Paik
    Cancer Res., 2018;0(0):.  2018
  62. Complex bile duct network formation within liver decellularized extracellular matrix hydrogels
    Authors: PL Lewis, J Su, M Yan, F Meng, SS Glaser, GD Alpini, RM Green, B Sosa-Pined, RN Shah
    Sci Rep, 2018;8(1):12220.  2018
  63. The ATR inhibitor AZD6738 synergizes with gemcitabine in vitro and in vivo to induce pancreatic ductal adenocarcinoma regression
    Authors: Y Wallez, CR Dunlop, TI Johnson, SB Koh, C Fornari, JW Yates, S Bernaldo d, A Lau, FM Richards, DI Jodrell
    Mol. Cancer Ther., 2018;0(0):.  2018
  64. Mechanistic distinctions between CHK1 and WEE1 inhibition guide the scheduling of triple therapy with gemcitabine
    Authors: SB Koh, Y Wallez, CR Dunlop, S Bernaldo d, TE Bapiro, FM Richards, DI Jodrell
    Cancer Res., 2018;0(0):.  2018
  65. Effects of Exposure to Acetaminophen and Ibuprofen on Fetal Germ Cell Development in Both Sexes in Rodent and Human Using Multiple Experimental Systems
    Authors: P Hurtado-Go, RA Anderson, J Macdonald, S van den Dr, K Kilcoyne, A Jørgensen, C McKinnell, S Macpherson, RM Sharpe, RT Mitchell
    Environ. Health Perspect., 2018;126(4):047006.  2018
  66. Screening, large-scale production and structure-based classification of cystine-dense peptides
    Authors: CE Correnti, MM Gewe, C Mehlin, AD Bandaranay, WA Johnsen, PB Rupert, MY Brusniak, M Clarke, SE Burke, W De Van Der, K Pilat, SM Turnbaugh, D May, A Watson, MK Chan, CD Bahl, JM Olson, RK Strong
    Nat. Struct. Mol. Biol., 2018;25(3):270-278.  2018
  67. Integration of distinct ShcA signaling complexes promotes breast tumor growth and tyrosine kinase inhibitor resistance
    Authors: JR Ha, R Ahn, HW Smith, V Sabourin, S H?bert, E Cepeda Cañ, YK Im, C Kleinman, WJ Muller, J Ursini-Sie
    Mol. Cancer Res., 2018;0(0):.  2018
  68. Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome
    Authors: VZ Wall, S Barnhart, JE Kanter, F Kramer, M Shimizu-Al, N Adhikari, TN Wight, JL Hall, KE Bornfeldt
    JCI Insight, 2018;3(11):.  2018
  69. TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue
    Authors: LA Velazquez-, A Perino, V Lemos, M Zietak, M Nomura, TWH Pols, K Schoonjans
    Nat Commun, 2018;9(1):245.  2018
  70. Raman micro-spectroscopy for accurate identification of primary human bronchial epithelial cells
    Authors: JM Surmacki, BJ Woodhams, A Haslehurst, BAJ Ponder, SE Bohndiek
    Sci Rep, 2018;8(1):12604.  2018
  71. miR-663a inhibits tumor growth and invasion by regulating TGF-?1 in hepatocellular carcinoma
    Authors: C Zhang, B Chen, A Jiao, F Li, N Sun, G Zhang, J Zhang
    BMC Cancer, 2018;18(1):1179.  2018
  72. A combination of SAHA and Quinacrine is effective in inducing cancer cell death in upper gastrointestinal cancers
    Authors: S Zhu, Z Chen, L Wang, D Peng, A Belkhiri, AC Lockhart, W El-Rifai
    Clin. Cancer Res., 2018;0(0):.  2018
  73. A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome
    Authors: JE Kanter, F Kramer, S Barnhart, JM Duggan, M Shimizu-Al, V Kothari, A Chait, SD Bouman, JA Hamerman, BF Hansen, GS Olsen, KE Bornfeldt
    Diabetes, 2018;0(0):.  2018
  74. Spatial patterning of liver progenitor cell differentiation mediated by cellular contractility and Notch signaling
    Authors: KB Kaylan, IC Berg, MJ Biehl, A Brougham-C, I Jain, SM Jamil, LH Sargeant, NJ Cornell, LT Raetzman, GH Underhill
    Elife, 2018;7(0):.  2018
  75. Lineage dynamics of murine pancreatic development at single-cell resolution
    Authors: LE Byrnes, DM Wong, M Subramania, NP Meyer, CL Gilchrist, SM Knox, AD Tward, CJ Ye, JB Sneddon
    Nat Commun, 2018;9(1):3922.  2018
  76. The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer
    Authors: EH Dakir, A Pickard, K Srivastava, CM McCrudden, SR Gross, S Lloyd, SD Zhang, A Margariti, R Morgan, PS Rudland, M El-Tanani
    Oncotarget, 2018;9(79):34889-34910.  2018
  77. HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome
    Authors: S di Martino, CA Amoreo, B Nuvoli, R Galati, S Strano, F Facciolo, G Alessandri, HI Pass, G Ciliberto, G Blandino, R De Maria, M Cioce
    Oncogene, 2018;0(0):.  2018
  78. Targeting PARP1 in XRCC1 deficient sporadic invasive breast cancer or pre-invasive ductal carcinoma in situ induces synthetic lethality and chemoprevention
    Authors: R Ali, A Al-Kawaz, MS Toss, AR Green, IM Miligy, KA Mesquita, C Seedhouse, S Mirza, V Band, EA Rakha, S Madhusudan
    Cancer Res., 2018;0(0):.  2018
  79. De novo NAD+ synthesis enhances mitochondrial function and improves health
    Authors: E Katsyuba, A Mottis, M Zietak, F De Franco, V van der Ve, K Gariani, D Ryu, L Cialabrini, O Matilainen, P Liscio, N Giacchè, N Stokar-Reg, D Legouis, S de Seigneu, J Ivanisevic, N Raffaelli, K Schoonjans, R Pellicciar, J Auwerx
    Nature, 2018;0(0):.  2018
  80. CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition
    Authors: L Qiu, X Tan, J Lin, RY Liu, S Chen, R Geng, J Wu, W Huang
    J Cancer, 2017;8(13):2626-2635.  2017
  81. Lack of constitutively active DNA repair sensitizes glioblastomas to Akt inhibition and induces synthetic lethality with radiation treatment in a p53-dependentmanner
    Authors: K Palanicham, D Patel, JR Jacob, KT Litzenberg, N Gordon, K Acus, SE Noda, A Chakravart
    Mol. Cancer Ther., 2017;0(0):.  2017
  82. Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation
    Authors: RLG Maus, JW Jakub, WK Nevala, TA Christense, K Noble-Orcu, Z Sachs, TJ Hieken, SN Markovic
    Front Immunol, 2017;8(0):358.  2017
  83. CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer
    Authors: D Wang, H Sun, J Wei, B Cen, RN DuBois
    Cancer Res., 2017;0(0):.  2017
  84. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy
    Authors: GS Cho, DI Lee, E Tampakakis, S Murphy, P Andersen, H Uosaki, S Chelko, K Chakir, I Hong, K Seo, HV Chen, X Chen, C Basso, SR Houser, GF Tomaselli, B O'Rourke, DP Judge, DA Kass, C Kwon
    Cell Rep, 2017;18(2):571-582.  2017
  85. Transcription factor ZNF148 is a negative regulator of human muscle differentiation
    Authors: J Bakke, WC Wright, AE Zamora, SS Ong, YM Wang, JD Hoyer, CT Brewer, PG Thomas, T Chen
    Sci Rep, 2017;7(1):8138.  2017
  86. Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP1-17
    Authors: JS Frieling, G Shay, V Izumi, ST Aherne, RG Saul, M Budzevich, J Koomen, CC Lynch
    Oncogene, 2017;0(0):.  2017
  87. BRCA2 hypomorphic missense variants confer moderate risks of breast cancer
    Authors: H Shimelis, RL Mesman, C Von Nicola, A Ehlen, L Guidugli, C Martin, FM Calleja, H Meeks, E Hallberg, J Hinton, J Lilyquist, C Hu, CM Aalfs, K Aittomaki, IL Andrulis, H Anton-Culv, V Arndt, MW Beckmann, JJ Benitez, N Bogdanova, SE Bojesen, MK Bolla, AL Borresen-D, H Brauch, P Brennan, H Brenner, A Broeks, B Brouwers, T Bruning, B Burwinkel, J Chang-Clau, G Chenevix-T, CY Cheng, JY Choi, JM Collée, A Cox, SS Cross, K Czene, H Darabi, J Dennis, T Dork, I Dos Santos, AM Dunning, PA Fasching, JD Figueroa, H Flyger, M Garcia-Clo, GG Giles, G Glendon, P Guenel, CA Haiman, P Hall, U Hamann, M Hartman, FB Hogervorst, A Hollestell, JL Hopper, H Ito, A Jakubowska, D Kang, VM Kosma, V Kristensen, KN Lai, D Lambrechts, L Le Marchan, J Li, A Lindblom, A Lophatanan, J Lubinski, E Machackova, A Mannermaa, S Margolin, F Marme, K Matsuo, H Miao, K Michailido, RL Milne, K Muir, SL Neuhausen, H Nevanlinna, JE Olson, C Olswold, JC Oosterwijk, A Osorio, P Peterlongo, J Peto, PD Pharoah, K Pylkäs, P Radice, MU Rashid, V Rhenius, A Rudolph, S Sangrajran, EJ Sawyer, MK Schmidt, MJ Schoemaker, CM Seynaeve, M Shah, CY Shen, MJ Shrubsole, XO Shu, SL Slager, MC Southey, DO Stram, AJ Swerdlow, SH Teo, I Tomlinson, D Torres, T Truong, CJ van Aspere, LE van der Ko, Q Wang, R Winqvist, AH Wu, JC Yu, W Zheng, Y Zheng, J Leary, LC Walker, L Foretova, F Fostira, K Claes, L Varesco, S Moghadasi, DF Easton, AB Spurdle, P Devilee, H Vrieling, AN Monteiro, DE Goldgar, A Carreira, MP Vreeswijk, FJ Couch
    Cancer Res, 2017;0(0):.  2017
  88. Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase
    Authors: PO Oladimeji, W Lin, CT Brewer, T Chen
    Sci Rep, 2017;7(0):46751.  2017
  89. HIF2? targeted RNAi therapeutic inhibits clear cell renal cell carcinoma
    Authors: SC Wong, W Cheng, H Hamilton, AL Nicholas, DH Wakefield, A Almeida, AV Blokhin, J Carlson, ZC Neal, V Subbotin, G Zhang, J Hegge, S Bertin, VS Trubetskoy, DB Rozema, DL Lewis, SB Kanner
    Mol. Cancer Ther., 2017;0(0):.  2017
  90. Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4
    Authors: LD Volk-Drape, KL Hall, AC Wilber, S Ran
    PLoS ONE, 2017;12(6):e0179257.  2017
  91. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4
    Authors: H Wang, X Huo, XR Yang, J He, L Cheng, N Wang, X Deng, H Jin, N Wang, C Wang, F Zhao, J Fang, M Yao, J Fan, W Qin
    Mol. Cancer, 2017;16(1):136.  2017
  92. Quantitative FastFUCCI assay defines cell cycle dynamics at single-cell level
    J. Cell. Sci., 2016;0(0):.  2016
  93. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
    Nature, 2016;0(0):.  2016
  94. Human keratinocytes have two interconvertible modes of proliferation.
    Authors: Roshan A, Murai K, Fowler J, Simons B, Nikolaidou-Neokosmidou V, Jones P
    Nat Cell Biol, 2016;18(2):145-56.  2016
  95. Targeting ?1-integrin signaling enhances regeneration in aged and dystrophic muscle in mice
    Authors: M Rozo, L Li, CM Fan
    Nat. Med, 2016;22(8):889-96.  2016
  96. Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
    Elife, 2016;5(0):.  2016
  97. SCAP/SREBP pathway is required for the full steroidogenic response to cyclic AMP
    Proc Natl Acad Sci USA, 2016;113(38):E5685-E5693.  2016
  98. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells
    Authors: Andrea Galli
    J. Hepatol., 2016;0(0):.  2016
  99. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate
    Oncotarget, 2016;0(0):.  2016
  100. Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer
    Sci Rep, 2016;6(0):29384.  2016
  101. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression
    J Exp Clin Cancer Res, 2016;35(1):142.  2016
  102. Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer.
    Authors: Hollmen M, Roudnicky F, Karaman S, Detmar M
    Sci Rep, 2015;5(0):9188.  2015
  103. CHK1 Inhibition Synergizes with Gemcitabine Initially by Destabilizing the DNA Replication Apparatus.
    Authors: Koh S, Courtin A, Boyce R, Boyle R, Richards F, Jodrell D
    Cancer Res, 2015;75(17):3583-95.  2015
  104. The effects of mycoplasma contamination upon the ability to form bioengineered 3D kidney cysts.
    Authors: DesRochers T, Kuo I, Kimmerling E, Ehrlich B, Kaplan D
    PLoS ONE, 2015;10(3):e0120097.  2015
  105. Expression of a versatile DC-targeting fusion protein using an Adenovirus expression system.
    Protein Expr. Purif., 2012;84(2):270-9.  2012
  106. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
    Authors: Sharma, Bhuvnesh, Manglik, V
    Oncogene, 2012;41(5):1570-6.  2012
  107. Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells.
    Authors: Mordant P, Loriot Y, Lahon B, Castier Y, Leseche G, Soria JC, Vozenin MC, Decraene C, Deutsch E
    PLoS ONE, 2011;6(10):e26073.  2011
  108. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
    Authors: Wang H, Wu J, Meng X
    Carcinogenesis, 2011;32(7):1033-42.  2011
  109. Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development.
    Authors: Menghi F, Jacques TS, Barenco M, Schwalbe EC, Clifford SC, Hubank M, Ham J
    Cancer Res., 2011;71(6):2045-55.  2011
  110. beta2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.
    Authors: Josson S, Nomura T, Lin JT, Huang WC, Wu D, Zhau HE, Zayzafoon M, Weizmann MN, Gururajan M, Chung LW
    Cancer Res., 2011;71(7):2600-10.  2011
  111. Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children.
    Authors: Goto H, Naruto T, Tanoshima R, Kato H, Yokosuka T, Yanagimachi M, Fujii H, Yokota S, Komine H
    Leuk. Res., 2009;33(10):1386-91.  2009
  112. Interval-specific congenic lines reveal quantitative trait Loci with penetrant lyme arthritis phenotypes on chromosomes 5, 11, and 12.
    Authors: Ma Y, Miller JC, Crandall H, Larsen ET, Dunn DM, Weiss RB, Subramanian M, Weis JH, Zachary JF, Teuscher C, Weis JJ
    Infect. Immun., 2009;77(8):3302-11.  2009

FAQs

  1. What are recommendations for cell culture numbers prior to evaluating supernatant in the kit?

    • For adherent cells, we recommend culturing cells to confluence prior to the assay. For suspension cells, we recommend culturing to a density of 0.5-1 x 106 cells/mL.

View all Cell Culture Product FAQs

Reviews for MycoProbe Mycoplasma Detection Kit

Average Rating: 5 (Based on 6 Reviews)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used MycoProbe Mycoplasma Detection Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


MycoProbe Mycoplasma Detection Kit
By Vincent Giacalone on 05/20/2021

This is a alternative to PCR for mycoplasma testing. I used it to test cell culture supernatants but can also be used for cell lysates. The positive control wells are in red and negative control are in green. 14 samples were measured in duplicate and after subtracting the negative control all were well below the lower threshold of 0.05. The kit assay requires about 6 hours to complete but mostly consists of incubation steps, one of which requires 65 degree water bath. The one downside is the kit is best for measuring large batches of samples all at once given the plate based format.

MycoProbe Mycoplasma Detection Kit CUL001B
MycoProbe Mycoplasma Detection Kit
By Anonymous on 05/05/2020

This is the best kit I have ever used for testing mycoplasma, better than PCR and fluorescence based assays. It can test both cells and media, both frozen and fresh samples. It does not require 2 weeks antibiotic free culture time. It takes about 5 to 6 hours to finish. The only not very convenient step is the 65C incubation in water bath.

MycoProbe Mycoplasma Detection Kit CUL001B
MycoProbe Mycoplasma Detection Kit
By Anonymous on 12/06/2019
MycoProbe Mycoplasma Detection Kit
By Leslie Priddy on 04/03/2018
MycoProbe Mycoplasma Detection Kit
By Anonymous on 07/07/2017
MycoProbe Mycoplasma Detection Kit
By Anonymous on 05/13/2016

Our lab has been using this kit for routine Mycoplasma testing of cultures for over 2 years now. The kit is highly sensitive and specific to Mycoplasma. The data is reproducible and more accurate than other tests, the size of the assay is adjustable (the kit comes as 12 8-well strips). You get reliable results in a few hours. Overall, great product and highly recommended.

MycoProbe Mycoplasma Detection Kit CUL001B